Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Clinical & Experimental Metastasis
|
September 25, 2004
Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839)
Stephen Hiscox, Liam Morgan, Denise Barrow, et al.
Clinical & Experimental Metastasis
|
March 31, 2007
Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells
Stephen Hiscox, Nicola J Jordan, Liam Morgan, et al.
Journal of Drug Targeting
|
December 8, 2005
HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines
Francesca Greco, María J Vicent, Neal A Penning, et al.
Journal of Cellular Biochemistry
|
March 31, 2009
Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells
Shefali Soni, Bor-Tyh Lin, Avery August, et al.
Breast Cancer Research and Treatment
|
December 8, 2005
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
Stephen Hiscox, Liam Morgan, Tim P Green, et al.
Pharmaceutical Research
|
July 16, 2008
In vitro effects on MCF-7 breast cancer cells of signal transduction inhibitor/tamoxifen/eicosapentaenoic acid combinations and their simultaneous delivery across skin
Zoë Davison, Carol Dutkowski, Julia M W Gee, et al.
The Biochemical Journal
|
July 4, 2003
Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters
Kathryn M Taylor, Helen E Morgan, Andrea Johnson, et al.
Endocrinology
|
June 28, 2008
ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells
Kathryn M Taylor, Petra Vichova, Nicola Jordan, et al.
Anticancer Research
|
August 15, 2002
Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen
Nigel J Bundred, Elizabeth Anderson, Robert I Nicholson, et al.
Breast Cancer Research and Treatment
|
September 21, 2004
Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells
Nicola J Jordan, Julia M W Gee, Denise Barrow, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Clinical & Experimental Metastasis
|
September 25, 2004
Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839)
Stephen Hiscox, Liam Morgan, Denise Barrow, et al.
Clinical & Experimental Metastasis
|
March 31, 2007
Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells
Stephen Hiscox, Nicola J Jordan, Liam Morgan, et al.
Journal of Drug Targeting
|
December 8, 2005
HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines
Francesca Greco, María J Vicent, Neal A Penning, et al.
Journal of Cellular Biochemistry
|
March 31, 2009
Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells
Shefali Soni, Bor-Tyh Lin, Avery August, et al.
Breast Cancer Research and Treatment
|
December 8, 2005
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
Stephen Hiscox, Liam Morgan, Tim P Green, et al.
Pharmaceutical Research
|
July 16, 2008
In vitro effects on MCF-7 breast cancer cells of signal transduction inhibitor/tamoxifen/eicosapentaenoic acid combinations and their simultaneous delivery across skin
Zoë Davison, Carol Dutkowski, Julia M W Gee, et al.
The Biochemical Journal
|
July 4, 2003
Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters
Kathryn M Taylor, Helen E Morgan, Andrea Johnson, et al.
Endocrinology
|
June 28, 2008
ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells
Kathryn M Taylor, Petra Vichova, Nicola Jordan, et al.
Anticancer Research
|
August 15, 2002
Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen
Nigel J Bundred, Elizabeth Anderson, Robert I Nicholson, et al.
Breast Cancer Research and Treatment
|
September 21, 2004
Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells
Nicola J Jordan, Julia M W Gee, Denise Barrow, et al.
Page
of 8